MoneyWorks4Me

Aarti Pharmalabs informs about outcome of board meeting

13 Dec 2024 Evaluate

Aarti Pharmalabs has informed that the Board of Directors has, at its meeting held today, based on the recommendation of the Nomination and Remuneration Committee, approved the appointment of Jeevan Mondkar (ACS: A22565) as the Company Secretary, Compliance Officer and Key Managerial Personnel of the Company with effect from December 13, 2024. The required details pursuant to SEBI Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, are annexed as Annexure A. The above information is also available on the website of the Company: www.aartipharmalabs.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..